IL80176A0 - 1-methyl-15alpha-alkylandrosta-1,4-diene-3,17-dione derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

1-methyl-15alpha-alkylandrosta-1,4-diene-3,17-dione derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL80176A0
IL80176A0 IL80176A IL8017686A IL80176A0 IL 80176 A0 IL80176 A0 IL 80176A0 IL 80176 A IL80176 A IL 80176A IL 8017686 A IL8017686 A IL 8017686A IL 80176 A0 IL80176 A0 IL 80176A0
Authority
IL
Israel
Prior art keywords
alkylandrosta
15alpha
diene
methyl
processes
Prior art date
Application number
IL80176A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL80176A0 publication Critical patent/IL80176A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL80176A 1985-11-01 1986-09-29 1-methyl-15alpha-alkylandrosta-1,4-diene-3,17-dione derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same IL80176A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853539244 DE3539244A1 (de) 1985-11-01 1985-11-01 1-methyl-15(alpha)-alkyl-androsta- 1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
IL80176A0 true IL80176A0 (en) 1986-12-31

Family

ID=6285220

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80176A IL80176A0 (en) 1985-11-01 1986-09-29 1-methyl-15alpha-alkylandrosta-1,4-diene-3,17-dione derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (16)

Country Link
EP (1) EP0225272B1 (da)
JP (1) JPS62155294A (da)
CN (1) CN86107158A (da)
AT (1) ATE41936T1 (da)
AU (1) AU6432986A (da)
DD (1) DD250319A5 (da)
DE (2) DE3539244A1 (da)
DK (1) DK515486A (da)
FI (1) FI864329A7 (da)
GR (1) GR880300115T1 (da)
HU (1) HU196079B (da)
IL (1) IL80176A0 (da)
NO (1) NO864365L (da)
NZ (1) NZ218071A (da)
PT (1) PT83659B (da)
ZA (1) ZA868333B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703722A1 (de) * 1987-02-04 1988-08-18 Schering Ag 1-methyl-15(alpha)-(1,2-dialkanoyloxyalkyl)-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3705990A1 (de) * 1987-02-20 1988-09-01 Schering Ag 1-methyl-15(alpha)-(1-oxyalkyl)-androsta-1,4-dien- 3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
NO864365L (no) 1987-05-04
DD250319A5 (de) 1987-10-08
EP0225272A1 (de) 1987-06-10
FI864329A7 (fi) 1987-05-02
HU196079B (en) 1988-09-28
DK515486D0 (da) 1986-10-28
PT83659B (en) 1988-08-30
FI864329A0 (fi) 1986-10-24
AU6432986A (en) 1987-05-07
ATE41936T1 (de) 1989-04-15
HUT43618A (en) 1987-11-30
ZA868333B (en) 1987-06-24
JPS62155294A (ja) 1987-07-10
GR880300115T1 (en) 1989-06-22
DK515486A (da) 1987-05-02
DE3539244A1 (de) 1987-05-07
PT83659A (en) 1986-11-01
CN86107158A (zh) 1987-08-05
DE3662693D1 (en) 1989-05-11
NO864365D0 (no) 1986-10-31
NZ218071A (en) 1989-01-06
EP0225272B1 (de) 1989-04-05

Similar Documents

Publication Publication Date Title
HK94190A (en) Substituted androsta-1,4-diene-3,17-diones and process for their preparation
WO1988000042A1 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
ZA899671B (en) Phosphinic acid substituted steroids as inhibitors of steroid 5-alpha-reductase
AU5936386A (en) Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them
AU4700389A (en) Phosphonic acid substituted steroids as steroid 5alpha- reductase inhibitors
AU579497B2 (en) Peptic ulcer treatment method
IL80176A0 (en) 1-methyl-15alpha-alkylandrosta-1,4-diene-3,17-dione derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
TW336235B (en) 3'-aziridino-anthracycline derivatives, process for preparating them and pharmaceutical composition containing them
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
DE3563971D1 (en) 1-alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them
DE3571441D1 (en) Process for the preparation of pregnane derivative
AU5847386A (en) Derivatives of 1,1,2,2-tetramethyl-1,2-bis-(2-fluoro-4- hydroxphenyl)-ethane
IE34308L (en) 11ß, 13ß-DIALKYLGONA-1,3,5(10)-TRIEN-3-OL 3-CYCLOALKYL¹ETHERS
AU4385885A (en) Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds
DE3371787D1 (en) 17-alpha-pregn-4-ene-3-oxo-21-carboxylic acid esters, process for the preparation thereof, and use thereof as medicinal agents
EP0296979A3 (en) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them
EP0139907A3 (en) Estrane derivatives
GB1495353A (en) Ascochlorin derivatives pharmaceutical composition containing the same and method of using the same
GR3003700T3 (da)
JPS5268196A (en) Bicyclomycin derivatives
IL67323A0 (en) New dehydrocardenolide derivatives,process for the preparation thereof and pharmaceutical preparations containing the same
IE872998L (en) 4-hydroxy-4-(substituted alkenyl)- cyclohexanecarboxylic¹acids
KR910000786A (ko) 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도